Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 132
Filtrar
Más filtros










Filtros aplicados
Intervalo de año de publicación
1.
Eur J Obstet Gynecol Reprod Biol ; 266: 111-113, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34624738

RESUMEN

Maternal morbidity and mortality remain stubborn highly in many parts of the world. Similarly Neonatal morbidity, mortality and five years survival in most of the under-resourced countries has not declined significantly over the past decades. Furthermore sexual reproductive health services provision has not met the needs of the women and there remains a huge unmet need for reliable contraception globally. This is the time for a global action plan and for all agencies to work together to achieve meaningful outcomes to improve health of women and their babies. Covid 19 pandemic has led to increase in gender based violence as well which is deplorable. European Board and College of Obstetrics and Gynaecology welcome this initiative and commits to work with all the stakeholders to improve safety and quality of care for women and the newborn.


Asunto(s)
COVID-19 , Ginecología , Obstetricia , Femenino , Humanos , Recién Nacido , Seguridad del Paciente , Embarazo , SARS-CoV-2
2.
BMC Infect Dis ; 21(1): 783, 2021 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-34372767

RESUMEN

BACKGROUND: The novel coronavirus disease 2019 (COVID-19) spreads rapidly among people and causes a pandemic. It is of great clinical significance to identify COVID-19 patients with high risk of death. METHODS: A total of 2169 adult COVID-19 patients were enrolled from Wuhan, China, from February 10th to April 15th, 2020. Difference analyses of medical records were performed between severe and non-severe groups, as well as between survivors and non-survivors. In addition, we developed a decision tree model to predict death outcome in severe patients. RESULTS: Of the 2169 COVID-19 patients, the median age was 61 years and male patients accounted for 48%. A total of 646 patients were diagnosed as severe illness, and 75 patients died. An older median age and a higher proportion of male patients were found in severe group or non-survivors compared to their counterparts. Significant differences in clinical characteristics and laboratory examinations were found between severe and non-severe groups, as well as between survivors and non-survivors. A decision tree, including three biomarkers, neutrophil-to-lymphocyte ratio, C-reactive protein and lactic dehydrogenase, was developed to predict death outcome in severe patients. This model performed well both in training and test datasets. The accuracy of this model were 0.98 in both datasets. CONCLUSION: We performed a comprehensive analysis of COVID-19 patients from the outbreak in Wuhan, China, and proposed a simple and clinically operable decision tree to help clinicians rapidly identify COVID-19 patients at high risk of death, to whom priority treatment and intensive care should be given.


Asunto(s)
COVID-19 , Adulto , China/epidemiología , Árboles de Decisión , Humanos , Recién Nacido , Masculino , Estudios Retrospectivos , Factores de Riesgo , SARS-CoV-2
3.
Trials ; 22(1): 532, 2021 Aug 12.
Artículo en Inglés | MEDLINE | ID: mdl-34384459

RESUMEN

BACKGROUND: Insomnia and sleep disturbances are common in pregnancy and have potentially significant consequences for both maternal and infant health. There is limited research examining the effectiveness of cognitive behavioral therapy for insomnia (CBT-I) during pregnancy. With increased distress and limited access to services during the COVID-19 pandemic, there is also an unprecedented need for telehealth delivery of treatment programs for pregnant women. The aims of this trial are to evaluate the impact of the Sleeping for Two adaptation of CBT-I in pregnancy (in-person or telehealth) versus treatment as usual (TAU) in reducing symptoms of insomnia (primary outcome), as well as increasing gestational length and reducing symptoms of depression (secondary outcomes). METHODS: A two-arm, single-blinded, parallel group randomized controlled trial (RCT) design with repeated measures will be used to evaluate the impact of CBT-I compared to TAU among a sample of 62 pregnant women, enrolled between 12 and 28 weeks of gestation, who self-identify as experiencing insomnia. Five weekly individual sessions of CBT-I will be delivered in person or via telehealth depending on physical distancing guidelines. Assessment of insomnia diagnosis by structured interview, self-reported insomnia symptom severity and sleep problems, and sleep quantity and quality as measured by a daily diary and actigraphy will occur at 12-28 weeks of pregnancy (T1), 1 week post-treatment (T2), and 6 months postpartum (T3). DISCUSSION: CBT-I delivered in pregnancy has the potential to reduce symptoms of insomnia and depression and could lead to reduced risk of preterm birth, all of which can minimize risk of negative maternal and child health and developmental consequences in the short (e.g., infant death) and long terms (e.g., developmental delays). This RCT builds on a successful open pilot trial conducted by our team and will provide further evaluation of a novel evidence-based treatment for pregnancy-related insomnia, which can be widely disseminated and used to treat individuals that are most in need of intervention. Findings will enhance understanding of pregnancy-related sleep problems, as well as means by which to improve the health and sleep of mothers and their children. TRIAL REGISTRATION: ClinicalTrials.gov NCT03918057. Registered on 17 April 2019.


Asunto(s)
COVID-19 , Terapia Cognitivo-Conductual , Trastornos del Inicio y del Mantenimiento del Sueño , Niño , Femenino , Humanos , Recién Nacido , Embarazo , Mujeres Embarazadas , Ensayos Clínicos Controlados Aleatorios como Asunto , SARS-CoV-2 , Sueño , Trastornos del Inicio y del Mantenimiento del Sueño/diagnóstico , Trastornos del Inicio y del Mantenimiento del Sueño/terapia , Resultado del Tratamiento
4.
Pediatr Infect Dis J ; 40(9): e323-e332, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-34397776

RESUMEN

BACKGROUND: Globally, very few childhood deaths have been attributed to coronavirus disease 2019 (COVID-19). We evaluated clinical, microbiologic and postmortem histopathologic findings in childhood deaths in whom severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified antemortem or postmortem. METHODS: Surveillance of childhood deaths was ongoing during the initial COVID-19 outbreak in South Africa from April 14, 2020, to August 31, 2020. All children hospitalized during this time had a SARS-CoV-2 test done as part of standard of care. Postmortem sampling included minimally invasive tissue sampling (MITS) of lung, liver and heart tissue; blood and lung samples for bacterial culture and molecular detection of viruses (including SARS-CoV-2) and bacteria. The cause of death attribution was undertaken by a multidisciplinary team and reported using World Health Organization framework for cause of death attribution. RESULTS: SARS-CoV-2 was identified on antemortem and/or postmortem sampling in 11.7% (20/171) of deceased children, including 13.2% (12/91) in whom MITS was done. Eighteen (90%) of 20 deaths with SARS-CoV-2 infection were <12 months age. COVID-19 was attributed in the causal pathway to death in 91.7% (11/12) and 87.5% (7/8) cases with and without MITS, respectively. Lung histopathologic features in COVID-19-related deaths included diffuse alveolar damage (n = 6, 54.5%), type 2 pneumocyte proliferation (n = 6, 54.5%) and hyaline membrane formation (n = 5, 36.4%). Culture-confirmed invasive bacterial disease was evident in 54.5% (6/11) of COVID-19 attributed deaths investigated with MITS. CONCLUSIONS: COVID-19 was in the causal pathway of 10.5% (18/171) of all childhood deaths under surveillance. The postmortem histopathologic features in fatal COVID-19 cases in children were consistent with reports on COVID-19 deaths in adults; although there was a high prevalence of invasive bacterial disease in the children.


Asunto(s)
COVID-19/mortalidad , SARS-CoV-2/aislamiento & purificación , Adolescente , COVID-19/complicaciones , COVID-19/patología , COVID-19/terapia , Niño , Preescolar , Femenino , Gastroenteritis/complicaciones , Humanos , Lactante , Recién Nacido , Masculino , Respiración Artificial , Enfermedades Respiratorias/complicaciones , Convulsiones/complicaciones , Sudáfrica/epidemiología
5.
Arch. argent. pediatr ; 119(4): S198-S211, agosto 2021. tab, ilus
Artículo en Español | LILACS, BINACIS | ID: biblio-1281043

RESUMEN

La pandemia ocasionada por el nuevo coronavirus (SARS-CoV-2), declarada por la Organización Mundial de la Salud OMS) en marzo de 2020, afecta a un reducido número de pacientes pediátricos, quienes presentan, en su mayoría, compromiso respiratorio leve y evolución favorable. Sin embargo, en niños previamente sanos, comenzó a observarse un aumento de casos definidos como síndrome inflamatorio multisistémico (SIM-C) o similar a Kawasaki (Kawasaki-like) asociado a la enfermedad por el nuevo coronavirus (COVID-19) (KL-C) que evolucionan al shock y requieren internación en la unidad de cuidados intensivos.Los cuadros de SIM-C y los KL-C se caracterizan por fiebre, signos de inflamación, síntomas gastrointestinales y disfunción cardiovascular; las formas graves de presentación tienen mayor incidencia de hipotensión y/o shock. En el laboratorio se observan marcadores de inflamación, hipercoagulabilidad y daño miocárdico. El tratamiento farmacológico de primera línea consiste en la administración de inmunoglobulina por vía intravenosa más ácido acetilsalicílico por vía oral.Se recomienda un abordaje multidisciplinario para un diagnóstico certero y un tratamiento temprano y eficaz para disminuir la morbimortalidad.


The pandemic caused by the SARS-CoV-2 virus declared by the WHO in March 11th 2020, affects a small number of pediatric patients, who mostly present mild respiratory compromise and favorable evolution.However began to be observed in previously healthy children, an increase in cases defined as "Multisystemic Inflammatory Syndrome" (MIS-C) or "Kawasaki-like" post-COVID 19 (KL-C) that evolve to shock and require hospitalization in the Pediatric Intensive Care Unit.MIS-C and KL-C are characterized by fever; signs of inflammation, gastrointestinal symptoms, and cardiovascular dysfunction, associated with sever forms of presentation with higher incidence of hypotension and/or shock. In the laboratory, markers of inflammation, hypercoagulability and myocardial damage are observed. First-line drug treatment consists of intravenous immunoglobulin plus oral acetylsalicylic acid.A multidisciplinary approach is recommended for an accurate diagnosis and an early and effective treatment, in order to reduce morbidity and mortality.


Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Preescolar , Niño , Adolescente , Síndrome de Respuesta Inflamatoria Sistémica/terapia , COVID-19/terapia , Antiinflamatorios no Esteroideos/uso terapéutico , Aspirina/uso terapéutico , Inmunoglobulinas Intravenosas/uso terapéutico , Síndrome de Respuesta Inflamatoria Sistémica/complicaciones , Síndrome de Respuesta Inflamatoria Sistémica/diagnóstico , Cuidados Críticos , Diagnóstico Diferencial , COVID-19/complicaciones , COVID-19/diagnóstico , Síndrome Mucocutáneo Linfonodular/complicaciones , Síndrome Mucocutáneo Linfonodular/diagnóstico , Síndrome Mucocutáneo Linfonodular/terapia
6.
Arch Argent Pediatr ; 119(4): S198-S211, 2021 08.
Artículo en Español | MEDLINE | ID: mdl-34309328

RESUMEN

The pandemic caused by the SARS-CoV-2 virus declared by the WHO in March 11th 2020, affects a small number of pediatric patients, who mostly present mild respiratory compromise and favorable evolution. However began to be observed in previously healthy children, an increase in cases defined as "Multisystemic Inflammatory Syndrome" (MIS-C) or "Kawasaki-like" post-COVID 19 (KLC) that evolve to shock and require hospitalization in the Pediatric Intensive Care Unit. MIS-C and KL-C are characterized by fever; signs of inflammation, gastrointestinal symptoms, and cardiovascular dysfunction, associated with sever forms of presentation with higher incidence of hypotension and/or shock. In the laboratory, markers of inflammation, hypercoagulability and myocardial damage are observed. Firstline drug treatment consists of intravenous immunoglobulin plus oral acetylsalicylic acid. A multidisciplinary approach is recommended for an accurate diagnosis and an early and effective treatment, in order to reduce morbidity and mortality.


Asunto(s)
COVID-19/diagnóstico , COVID-19/terapia , Síndrome de Respuesta Inflamatoria Sistémica/diagnóstico , Síndrome de Respuesta Inflamatoria Sistémica/terapia , Adolescente , Antiinflamatorios/uso terapéutico , COVID-19/fisiopatología , Prueba de COVID-19 , Niño , Preescolar , Terapia Combinada , Cuidados Críticos/métodos , Diagnóstico Diferencial , Diagnóstico Precoz , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Factores Inmunológicos/uso terapéutico , Lactante , Recién Nacido , Terapia Respiratoria/métodos , Síndrome de Respuesta Inflamatoria Sistémica/fisiopatología
7.
Am J Pathol ; 191(9): 1610-1623, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34111431

RESUMEN

Despite occasional reports of vertical transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy, the question of placental infection and its consequences for the newborn remain unanswered. Herein, we analyzed the placentas of 31 coronavirus disease 2019-positive mothers by reverse transcriptase PCR, immunohistochemistry, and in situ hybridization. Only one case of placental infection was detected, which was associated with intrauterine demise of the fetus. Differentiated primary trophoblasts were then isolated from nonpathologic human placentas at term, differentiated, and exposed to SARS-CoV-2 virions. Unlike for positive control cells Vero E6, the virus inside cytotrophoblasts and syncytiotrophoblasts or in the supernatant 4 days after infection was undetectable. As a mechanism of defense, we hypothesized that trophoblasts at term do not express angiotensin-converting enzyme 2 and transmembrane protease serine 2 (TMPRSS2), the two main host membrane receptors for SARS-CoV-2 entry. The quantification of these proteins in the placenta during pregnancy confirmed the absence of TMPRSS2 at the surface of the syncytium. Surprisingly, a transiently induced experimental expression of TMPRSS2 did not allow the entry or replication of the virus in differentiated trophoblasts. Altogether, these results underline that trophoblasts are not likely to be infected by SARS-CoV-2 at term, but raise concern about preterm infection.


Asunto(s)
Enzima Convertidora de Angiotensina 2/biosíntesis , COVID-19 , Regulación Enzimológica de la Expresión Génica , Enfermedades Placentarias , Complicaciones Infecciosas del Embarazo , SARS-CoV-2/metabolismo , Serina Endopeptidasas/biosíntesis , Trofoblastos , Internalización del Virus , Adulto , COVID-19/enzimología , COVID-19/patología , Femenino , Humanos , Enfermedades Placentarias/enzimología , Enfermedades Placentarias/patología , Embarazo , Complicaciones Infecciosas del Embarazo/enzimología , Complicaciones Infecciosas del Embarazo/patología , Trofoblastos/enzimología , Trofoblastos/patología
8.
Neonatal Netw ; 40(3): 140-145, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-34088859

RESUMEN

The impact of the COVID-19 pandemic upon the health care landscape has prompted many organizations to revise policies in response to ever-changing guidelines and recommendations regarding safe breastfeeding practices. The application of these professional guidelines into clinical practice is fraught with barriers, inconsistencies, and often-minimal evidential support. Key concerns for health care providers and patients include antenatal versus postnatal transmission, milk transmission, and separation care versus rooming-in, including the subsequent impacts upon breastfeeding and bonding. While SARS-CoV-2 is a novel virus, the volume of literature to support best practice for couplet care continues to be developed at a rapid pace. The benefits of breastfeeding are steeped in evidence and outweigh the potential risk of transmission of COVID-19 from mother to newborn. Health care organizations must continue to seek guidance for policy revision within the ever-growing body of evidence for best practice and evaluate current practices for feasibility during and after hospitalization.


Asunto(s)
Lactancia Materna/métodos , Lactancia Materna/psicología , COVID-19/psicología , Promoción de la Salud/métodos , Madres/psicología , Enfermería Neonatal/normas , Guías de Práctica Clínica como Asunto , Adulto , Femenino , Humanos , Recién Nacido , Pandemias , Embarazo , SARS-CoV-2
9.
Neonatal Netw ; 40(3): 146-154, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-34088860

RESUMEN

Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, has overwhelmed health care systems in 2020, affecting millions of lives worldwide. There have, however, been few reports of the effect this virus has on the newborn population. This case study presents an infant with a vertical transmission of COVID-19, including symptoms, diagnosis, and management, to help inform care for the COVID-19-positive infant.


Asunto(s)
COVID-19/diagnóstico , COVID-19/enfermería , COVID-19/fisiopatología , COVID-19/transmisión , Transmisión Vertical de Enfermedad Infecciosa , Enfermería Neonatal/normas , Guías de Práctica Clínica como Asunto , Adulto , Femenino , Humanos , Recién Nacido , Masculino , SARS-CoV-2
10.
Neonatal Netw ; 40(3): 161-174, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-34088862

RESUMEN

Early recommendations to separate mothers from their newborns during the coronavirus disease 2019 (COVID-19) pandemic have created a detrimental separation practice. This article presents a review of the latest information regarding the (1) 3 modes of transmission of the virus to the neonate; (2) incidence, clinical signs, and severity of COVID-19 in the neonate; (3) factors to be considered to balance risk and benefits of separation and skin-to-skin contact (SSC) when conducting shared decision making; and (4) compendium of published SSC guidelines; and concludes with recommendations for safe practice of SSC to prevent and/or restrict COVID-19 infection in neonates.


Asunto(s)
COVID-19/psicología , Método Madre-Canguro/psicología , Método Madre-Canguro/normas , Relaciones Madre-Hijo/psicología , Madres/psicología , Enfermería Neonatal/normas , Guías de Práctica Clínica como Asunto , Adulto , Femenino , Humanos , Recién Nacido , Masculino , Pandemias , Embarazo , SARS-CoV-2
11.
Neonatal Netw ; 40(3): 175-182, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-34088863

RESUMEN

The novel coronavirus disease 2019 (COVID-19), appeared in the United States over 1 year ago. This virus has a wide range of presentations, from being asymptomatic to causing severe acute respiratory syndrome, which can lead to death. It has led to a worldwide effort to find effective treatments, from repurposed medications to new discoveries, as well as the push to develop effective vaccines. As the race to fight this pandemic unfolds, this column provides what is currently available to combat this virus, how it has been utilized in the pregnant population, and what data have been made available about how these treatments affect fetal development and the neonate.


Asunto(s)
COVID-19/tratamiento farmacológico , COVID-19/prevención & control , COVID-19/transmisión , Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Servicios de Salud Materna/normas , Enfermería Neonatal/normas , Síndrome Respiratorio Agudo Grave/tratamiento farmacológico , Síndrome Respiratorio Agudo Grave/prevención & control , Adulto , Antivirales/uso terapéutico , COVID-19/epidemiología , Femenino , Humanos , Recién Nacido , Masculino , Guías de Práctica Clínica como Asunto , Síndrome Respiratorio Agudo Grave/epidemiología , Síndrome Respiratorio Agudo Grave/transmisión , Estados Unidos/epidemiología
12.
Neonatal Netw ; 40(3): 183-186, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-34088864

RESUMEN

COVID-19's first wave created chaos for new NICU families as they struggled to cope with the challenge of a fragile infant along with a pandemic. Safety was paramount due to a lack of understanding around how the virus transmits, but much has been learned since then. The next wave of the virus needs to have a rethink around family separation. World leader organization European Foundation for the Care of Newborn Infants (EFCNI) provides insight into the challenges with the first wave and suggests ideas around rethinking how families interact with their baby in the subsequent waves.


Asunto(s)
COVID-19/psicología , Unidades de Cuidado Intensivo Neonatal/normas , Cuidado Intensivo Neonatal/psicología , Cuidado Intensivo Neonatal/normas , Relaciones Madre-Hijo/psicología , Guías de Práctica Clínica como Asunto , Adulto , Separación Familiar , Femenino , Humanos , Recién Nacido , Recien Nacido Prematuro , Masculino , SARS-CoV-2
13.
BMJ Open ; 11(6): e049120, 2021 06 29.
Artículo en Inglés | MEDLINE | ID: mdl-34187829

RESUMEN

INTRODUCTION: Fetal growth restriction (FGR) is a major contributor to fetal and neonatal morbidity and mortality with intrauterine, neonatal and lifelong complications. This study explores maternal obstructive sleep apnoea (OSA) as a potentially modifiable risk factor for FGR. We hypothesise that, in pregnancies complicated by FGR, treating mothers who have OSA using positive airway pressure (PAP) will improve birth weight and neonatal outcomes. METHODS AND ANALYSIS: The Sleep Apnea and Fetal Growth Restriction study is a prospective, block-randomised, single-blinded, multicentre, pragmatic controlled trial. We enrol pregnant women aged 18-50, between 22 and 31 weeks of gestation, with established FGR based on second trimester ultrasound, who do not have other prespecified known causes of FGR (such as congenital anomalies or intrauterine infection). In stage 1, participants are screened by questionnaire for OSA risk. If OSA risk is identified, participants proceed to stage 2, where they undergo home sleep apnoea testing. Participants are determined to have OSA if they have an apnoea-hypopnoea index (AHI) ≥5 (if the oxygen desaturation index (ODI) is also ≥5) or if they have an AHI ≥10 (even if the ODI is <5). These participants proceed to stage 3, where they are randomised to nightly treatment with PAP or no PAP (standard care control), which is maintained until delivery. The primary outcome is unadjusted birth weight; secondary outcomes include fetal growth velocity on ultrasound, enrolment-to-delivery interval, gestational age at delivery, birth weight corrected for gestational age, stillbirth, Apgar score, rate of admission to higher levels of care (neonatal intensive care unit or special care nursery) and length of neonatal stay. These outcomes are compared between PAP and control using intention-to-treat analysis. ETHICS AND DISSEMINATION: This study has been approved by the Institutional Review Boards at Washington University in St Louis, Missouri; Hadassah Hebrew University Medical Center, Jerusalem; and the University of Rochester, New York. Recruitment began in Washington University in November 2019 but stopped from March to November 2020 due to COVID-19. Recruitment began in Hadassah Hebrew University in March 2021, and in the University of Rochester in May 2021. Dissemination plans include presentations at scientific conferences and scientific publications. TRIAL REGISTRATION NUMBER: NCT04084990.


Asunto(s)
COVID-19 , Apnea Obstructiva del Sueño , Femenino , Retardo del Crecimiento Fetal , Humanos , Recién Nacido , Missouri , Estudios Multicéntricos como Asunto , New York , Embarazo , Estudios Prospectivos , Ensayos Clínicos Controlados Aleatorios como Asunto , SARS-CoV-2 , Mortinato , Washingtón
14.
J Korean Med Sci ; 36(23): e166, 2021 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-34128597

RESUMEN

BACKGROUND: This study presents a framework for determining the allocation and distribution of the limited amount of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: After analyzing the pandemic strategies of the major organizations and countries and with a literature review conducted by a core panel, a modified Delphi survey was administered to 13 experts in the fields of vaccination, infectious disease, and public health in the Republic of Korea. The following topics were discussed: 1) identifying the objectives of the vaccination strategy, 2) identifying allocation criteria, and 3) establishing a step-by-step vaccination framework and prioritization strategy based on the allocation criteria. Two rounds of surveys were conducted for each topic, with a structured questionnaire provided via e-mail in the first round. After analyzing the responses, a meeting with the experts was held to obtain consensus on how to prioritize the population groups. RESULTS: The first objective of the vaccination strategy was maintenance of the integrity of the healthcare system and critical infrastructure, followed by reduction of morbidity and mortality and reduction of community transmission. In the initial phase, older adult residents in care homes, high-risk health and social care workers, and personal support workers who work in direct contact with coronavirus disease 2019 (COVID-19) patients would be prioritized. Expansion of vaccine supply would allow immunization of older adults not included in phase 1, followed by healthcare workers not previously included and individuals with comorbidities. Further widespread vaccine supply would ensure availability to the extended adult age groups (50-64 years old), critical workers outside the health sector, residents who cannot socially distance, and, eventually, the remaining populations. CONCLUSION: This survey provides the much needed insight into the decision-making process for vaccine allocation at the national level. However, flexibility in adapting to strategies will be essential, as new information is constantly emerging.


Asunto(s)
Vacunas contra la COVID-19/uso terapéutico , COVID-19/epidemiología , COVID-19/prevención & control , Técnica Delfos , Asignación de Recursos , SARS-CoV-2 , Adolescente , Adulto , Anciano , Niño , Preescolar , Toma de Decisiones , Personal de Salud , Humanos , Lactante , Recién Nacido , Persona de Mediana Edad , Pandemias/prevención & control , Salud Pública , República de Corea/epidemiología , Encuestas y Cuestionarios , Vacunación , Adulto Joven
15.
Goiânia; SES-GO; 15; 21 maio 2021. 1-52 p. ilus, tab.
No convencional en Portugués | LILACS, Coleciona SUS, CONASS, SES-GO | ID: biblio-1096093

RESUMEN

O surto da doença respiratória causada pelo novo coronavírus (SARS-CoV-2) aconteceu na cidade de Wuhan, capital da província de Hubei, na China, em dezembro de 2019, a qual disseminou-se de forma acelerada e, logo, atingiu mais de uma centena de países dos cinco continentes. Em 12 de março de 2020, a situação foi caracterizada como pandemia pela Organização Mundial de Saúde (OMS, 2020). Em razão da disseminação o do Coronavírus pelo mundo, o Ministério da Saúde declarou Emergência de Saúde Pública de Importância Nacional (ESPIN) em decorrência da infecção pelo novo coronavírus (COVID-19) e estabeleceu o Centro de Operações de Emergência em Saúde Pública (COE-COVID-19) como mecanismo de gestão coordenada da resposta à ESPIN no país (BRASIL, 2020a). Seguindo a linha mundial, o Ministério da Saúde elaborou e publicou "Plano de Contingência Nacional para Infecção Humana pelo Novo Coronavírus COVID-19" para organizar a detecção, monitoramento e resposta dos serviços de saúde à doença (BRASIL, 2020b). O Estado de Goiás instituiu o Centro de Operações Estratégicas de Saúde Pública (COE) em 18 de fevereiro de 2020 (GOIÁS, 2020a). E, seguindo as orientações nacionais, propõe o presente PLANO ESTADUAL DE CONTINGÊNCIA PARA O ENFRENTAMENTO DA DOENÇA PELO CORONAVÍRUS (COVID-19), a fim de organizar e fortalecer as políticas públicas de saúde, visto que, para que atinjam eficácia e eficiência, é necessário atuação conjunta e ordenada dos entes federados, bem como dos setores públicos e privados.


The outbreak of respiratory disease caused by the new coronavirus (SARS-CoV-2) occurred in Wuhan city, capital of Hubei province, China, in December 2019, which spread rapidly and thus reached more than a hundred countries on five continents. On March 12, 2020, the situation was characterized as a pandemic by the World Health Organization (WHO, 2020). Due to the spread of Coronavirus around the world, the Ministry of Health declared a Public Health Emergency of National Importance (ESPIN) due to infection by the new coronavirus (COVID-19) and established the Center for Emergency Operations in Public Health (COE-COVID-19) as a mechanism for coordinated management of the response to ESPIN in the country (BRASIL, 2020a). Following the global line, the Ministry of Health elaborated and published "National Contingency Plan for Human Infection by the New Coronavirus COVID-19" to organize the detection, monitoring and response of health services to the disease (BRASIL, 2020b). The State of Goiás established the Center for Strategic Operations of Public Health (COE) on February 18, 2020 (GOIÁS, 2020a). And, following the national guidelines, it proposes this State CONTINGENCY PLAN FOR COPING WITH CORONAVIRUS DISEASE (COVID-19), in order to organize and strengthen public health policies, since, in order to achieve effectiveness and efficiency, joint and orderly action of federal entities, as well as public and private sectors, is necessary.


Asunto(s)
Humanos , Masculino , Femenino , Embarazo , Recién Nacido , Lactante , Preescolar , Niño , Adolescente , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Adulto Joven , COVID-19/complicaciones , COVID-19/diagnóstico , COVID-19/prevención & control , COVID-19/transmisión , Pandemias
16.
J Trauma Nurs ; 28(3): 203-208, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33949357

RESUMEN

BACKGROUND: The American College of Surgeons (ACS), Committee on Trauma, trauma center verification process is designed to help hospitals improve trauma care. Due to the COVID-19 pandemic social distancing restrictions, performing virtual site visits was piloted. OBJECTIVE: The purpose of this article is to describe the first pilot ACS pediatric trauma center virtual reverification visit performed in the United States. METHODS: This is a descriptive review of a 2020 pilot virtual Level I pediatric trauma center reverification visit. In-person site visit checklists were altered to adjust to the virtual format. All documents, prereview questionnaire, patient charts, and resource documents were prepared electronically. Collaboration with the departments of information technology, clinical education and informatics, and the general counsel's office prepared the infrastructure to allow reviewers access to protected health information. RESULTS: Multiple hospital departments collaborated to facilitate the transition to an electronic format. Organized virtual meeting room scheduling, communications, and coordination between the ACS staff, the reviewers, and the various hospital departments resulted in a successful virtual visit. CONCLUSION: Lessons learned and opportunities for improvement were identified for this first-ever pilot virtual pediatric trauma center reverification site visit. Once the information technology logistic questions were answered, allowing reviewers protected health information access, the general program and document preparation for a virtual trauma reverification site visit was similar to an in-person site visit. Although the review day agenda was similar, execution challenges were identified.


Asunto(s)
COVID-19 , Certificación/normas , Guías como Asunto , Unidades de Cuidado Intensivo Pediátrico/normas , Centros Traumatológicos/normas , Realidad Virtual , Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Proyectos Piloto , SARS-CoV-2 , Encuestas y Cuestionarios , Estados Unidos
18.
J Perinatol ; 41(5): 988-997, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33850282

RESUMEN

OBJECTIVE: To evaluate COVID-19 pandemic preparedness, available resources, and guidelines for neonatal care delivery among neonatal health care providers in low- and middle-income countries (LMICs) across all continents. STUDY DESIGN: Cross-sectional, web-based survey administered between May and June, 2020. RESULTS: Of 189 invited participants in 69 LMICs, we received 145 (77%) responses from 58 (84%) countries. The pandemic provides significant challenges to neonatal care, particularly in low-income countries. Respondents noted exacerbations of preexisting shortages in staffing, equipment, and isolation capabilities. In Sub-Saharan Africa, 9/35 (26%) respondents noted increased mortality in non-COVID-19-infected infants. Clinical practices on cord clamping, isolation, and breastfeeding varied widely, often not in line with World Health Organization guidelines. Most respondents noted family access restrictions, and limited shared decision-making. CONCLUSIONS: Many LMICs face an exacerbation of preexisting resource challenges for neonatal care during the pandemic. Variable approaches to care delivery and deviations from guidelines provide opportunities for international collaborative improvement.


Asunto(s)
COVID-19/epidemiología , Adhesión a Directriz/estadística & datos numéricos , Recursos en Salud/provisión & distribución , Mortalidad Infantil , Cuidado Intensivo Neonatal/normas , Estudios Transversales , Países en Desarrollo , Guías como Asunto , Encuestas de Atención de la Salud , Humanos , Lactante , Recién Nacido , Cuidado Intensivo Neonatal/organización & administración , Pobreza
19.
Saudi Med J ; 42(4): 355-362, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33795490

RESUMEN

Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and viral pneumonia in pediatrics worldwide. In the Kingdom of Saudi Arabia (KSA), the prevalence of RSV is 23.5% in pediatric patients with acute lower respiratory tract illness. Coronavirus disease (COVID-19) poses critical public health and socioeconomic challenges in KSA. The Saudi Pediatric Pulmonology Association (SPPA), a subsidiary of the Saudi Thoracic Society (STS), developed a task force to determine the potential challenges and barriers to the RSV immunoprophylaxis program during the era of COVID-19 and to compose a practical, nationwide, and multidisciplinary approach to address these challenges. Some of the recommendations to manage these challenges include increasing the number of RSV immunoprophylaxis clinics, drive-thru visits, home-care services, and swift referrals to the RSV immunoprophylaxis program specialists. Additional training is required for healthcare personnel to add RSV immunoprophylaxis to the regular immunization schedule.


Asunto(s)
Antivirales/uso terapéutico , Bronquiolitis Viral/prevención & control , Atención a la Salud/métodos , Programas de Inmunización/métodos , Palivizumab/uso terapéutico , Infecciones por Virus Sincitial Respiratorio/prevención & control , Comités Consultivos , COVID-19/epidemiología , COVID-19/prevención & control , Servicios de Atención de Salud a Domicilio , Humanos , Lactante , Recién Nacido , Inyecciones , Neumología , SARS-CoV-2 , Arabia Saudita , Sociedades Médicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...